Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • BLOG
    • IPILOGUE EDITORS
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
  • INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • OTHER ACTIVITIES
    • IP WRITING CHALLENGE
    Home
    >
    pharmaceuticals

    Tag: pharmaceuticals

    January 11, 2017in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
    922

    What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work

    This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…

    Read more
    January 13, 2014in Blogs, Infringement, IP, IP Intensive, IP Reform, Patents, Pharmaceutical Drugs0by Editor
    274

    IP Intensive Program: Experiential Learning at Actavis

    My 10 week internship at Actavis’ Canadian arm (formerly known as Cobalt), through Osgoode’s IP Intensive Program coincided with a very exciting time for the company. The company recently expanded…

    Read more
    November 2, 2012in IP0by Editor
    606

    Canada v. GSK - Intellectual Property Rights and the Arm's Length Principle

    In an eagerly anticipated decision, the Supreme Court of Canada released its judgment on Canada v. GlaxoSmithKline Inc., 2012 SCC 52 (Glaxo SCC, affirming 2010 FCA 201 [Glaxo FCA]). (more…)

    Read more
    July 23, 2012in Patentability, Patents, Pharmaceutical Drugs2by Editor
    436

    Allergan Inc. c. Canada (Health), 2012 FC 767: Comity or Tragedy?

    A somewhat confusing victory for Allergan Inc. was won on June 18th, as the Honourable Justice Hughes upheld their patent on COMBIGAN despite the fact that their invention was ruled…

    Read more
    April 2, 2012in Access to Medicines, Feature Post, Infringement, IP, Patents, Pharmaceutical Drugs0by Editor
    225

    India’s First Compulsory Licence: Patents vs Public Health?

    In a move with far reaching implications for the debates around pharmaceutical patents, innovation and access to medicines, the Indian patent office issued its first ever compulsory licence in the…

    Read more
    February 24, 2012in IP, Pharmaceutical Drugs1by Editor
    738

    WHO Resolution Intended to Address Global Counterfeit Drug Market

    On January 21, the WHO 130th WHO Executive Board (EB) adopted a resolution for agenda item 6.13 “substandard/spurious/falsely-labelled/falsified/counterfeit medical products” [SFFC]. The resolution is intended to address the growing prevalence…

    Read more

    Posts navigation

    1 2
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736